Epigenetically altered wound healing in keloid fibroblasts

Area of Science:

• Dermatology
• Fibrosis Research
• Epigenetics

Background:

• Keloids are benign dermal tumors resulting from abnormal wound healing in susceptible individuals.
• Current keloid treatments are unsatisfactory, and the underlying mechanisms remain unclear.
• Previous studies identified glucocorticoid resistance and altered gene regulation in keloid fibroblasts.

Purpose of the Study:

• To investigate the molecular and epigenetic differences between keloid and normal scar fibroblasts.
• To identify specific signaling pathways and genes involved in keloid pathogenesis.
• To explore potential epigenetic mechanisms driving keloid formation.

Main Methods:

• Culturing fibroblasts from normal scars and keloid nodules.
• Analyzing gene expression patterns, including Wnt and IGF/IGFBP5 pathways.
• Performing in vivo protein expression analysis in keloid tissue.
• Utilizing ChIP-chip analysis, Trichostatin A, and 5-aza-2'-deoxycytidine to assess epigenetic modifications.

Main Results:

• Keloid fibroblasts display decreased expression of SFRP1, MMP3, and DPT, and increased expression of IGFBP5 and JAG1 compared to normal fibroblasts.
• In vivo studies show decreased SFRP1/SFRP2 and increased IGFBP5 protein levels in proliferative keloid tissue.
• Fibroblast altered responses and gene regulation patterns persist throughout most of their culture lifespan.
• Preliminary epigenetic analyses suggest altered DNA methylation and histone acetylation patterns in keloid fibroblasts.

Conclusions:

• Keloid formation involves epigenetic alterations in fibroblasts, affecting key fibrotic signaling pathways.
• These epigenetic changes contribute to the characteristic abnormal wound healing and glucocorticoid resistance seen in keloids.
• Understanding these epigenetic modifications may lead to novel therapeutic strategies for keloid management.